Exploring Epidermal Growth Factor Receptor (EGFR) inhibitor features: The role of fused dioxygenated rings on the quinazoline scaffold
2010-01-01 Chilin, A.; Conconi, M. T.; Marzaro, G.; Guiotto, A.; Urbani, L.; Tonus, F.; Parnigotto, P.
Psoralenquinones as a novel class of proteasome inhibitors: Design, synthesis and biological evaluation
2011-01-01 Marzaro, G.; Gandin, V.; Marzano, C.; Guiotto, A.; Chilin, A.
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors
2011-01-01 Marzaro, G.; Chilin, A.; Guiotto, A.; Uriarte, E.; Brun, P.; Castagliuolo, I.; Tonus, F.; González-Díaz, H.
A microwave improvement in the synthesis of the quinazoline scaffold
2007-01-01 Chilin, A.; Marzaro, G.; Zanatta, S.; Guiotto, A.
Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: Design, synthesis and biological effects
2011-01-01 Borgatti, M.; Chilin, A.; Piccagli, L.; Lampronti, I.; Bianchi, N.; Mancini, I.; Marzaro, G.; Francesco, Dall'Acqua; Guiotto, A.; Gambari, R.
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: Synthesis, molecular modeling, 3D-QSAR, and biological evaluation
2013-01-01 Marzaro, G.; Guiotto, A.; Borgatti, M.; Finotti, A.; Gambari, R.; Breveglieri, G.; Chilin, A.
Quinazoline derivatives as potential anticancer agents: A patent review (2007 - 2010)
2012-01-01 Marzaro, G.; Guiotto, A.; Chilin, A.
Quinazoline-based multi-tyrosine kinase inhibitors: Synthesis, modeling, antitumor and antiangiogenic properties
2013-01-01 Conconi, M. T.; Marzaro, G.; Urbani, L.; Zanusso, I.; Di Liddo, R.; Castagliuolo, I.; Brun, P.; Tonus, F.; Ferrarese, A.; Guiotto, A.; Chilin, A.
Photochemical and photobiological studies on furoquinazolines as new psoralen analogs
2014-01-01 Miolo, G.; Salvador, A.; Mazzoli, A.; Spalletti, A.; Marzaro, G.; Chilin, A.
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G\>A) polymorphic A?-globin gene sequences mutated in ?-thalassemia
2019-01-01 Gemmo, C.; Breveglieri, G.; Marzaro, G.; Lampronti, I.; Cosenza, L. C.; Gasparello, J.; Zuccato, C.; Fabbri, E.; Borgatti, M.; Chilin, A.; Finotti, A.; Gambari, R.
Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib
2019-01-01 Poratti, M.; Marzaro, G.
Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents
2017-01-01 Carbajales, C.; Sawada, J. -I.; Marzaro, G.; Sotelo, E.; Escalante, L.; S('a)nchez-D('i)az Marta, A.; Garc('i)a-Mera, X.; Asai, A.; Coelho, A.
Discovery of wtRET and V804MRET Inhibitors: From Hit to Lead
2017-01-01 Mologni, L.; Dalla Via, M.; Chilin, A.; Palumbo, M.; Marzaro, G.
A new access to quinazolines from simple anilines
2006-01-01 Chilin, A.; Marzaro, G.; Zanatta, S.; Barbieri, V.; Pastorini, G.; Manzini, P.; Guiotto, A.
A novel approach to quinazolin-4(3H)-one via quinazoline oxidation: an improved synthesis of 4-anilinoquinazolines
2010-01-01 Marzaro, G.; Guiotto, A.; Pastorini, G.; Chilin, A.
Targeting kinases with anilinopyrimidines: Discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily
2015-01-01 Gandin, V.; Ferrarese, A.; Dalla Via, M.; Marzano, C.; Chilin, A.; Marzaro, G.
Early evaluation of copper radioisotope production at ISOLPHARM
2018-01-01 Borgna, F.; Ballan, M.; Favaretto, C.; Verona, M.; Tosato, M.; Caeran, M.; Corradetti, S.; Andrighetto, A.; Di Marco, V.; Marzaro, G.; Realdon, N.
Autogrid-based clustering of kinases: Selection of representative conformations for docking purposes
2014-01-01 Marzaro, G.; Ferrarese, A.; Chilin, A.
The moss Macromitrium richardii (Orthotrichaceae) with sporophyte and calyptra enclosed in Hymenaea resin from the Dominican Republic
2013-01-01 Heinrichs, J.; Vitt, D. H.; Schäfer-Verwimp, A.; Ragazzi, E.; Marzaro, G.; Grimaldi, D. A.; Nascimbene, P. C.; Feldberg, K.; Schmidt, A. R.
Known triterpenes and their derivatives as scaffolds for the development of new therapeutic agents for cancer
2018-01-01 Peron, G.; Marzaro, G.; Dall?acqua, S.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 01 Contributo in rivista70807
- 02 Contributo in volume1
Data di pubblicazione
- In corso di stampa141
- 2020 - 202719798
- 2010 - 201924484
- 2000 - 200914917
- 1990 - 19996948
- 1980 - 19892883
- 1970 - 19791137
- 1960 - 1969499
- 1958 - 19591
Editore
- Elsevier BV:PO Box 211, 1000 AE A...81
- Lippincott, Williams & Wilkins:53...71
- Springer Verlag Germany:Tiergarte...65
- Elsevier Science Limited:Oxford F...45
- Blackwell Science Limited:PO Box ...43
- Giuffre Editore Spa:via Busto Ars...42
- Edizioni Minerva Medica:Corso Bra...41
- Elsevier Science Incorporated / N...35
- John Wiley & Sons Incorporated:Cu...33
- Academic Press Incorporated:6277 ...32
Rivista
- PLOS ONE431
- INTERNATIONAL JOURNAL OF MOLECULA...296
- SCIENTIFIC REPORTS282
- CLINICAL CHEMISTRY AND LABORATORY...233
- BLOOD228
- LA RADIOLOGIA MEDICA222
- STUDIUM IURIS217
- JOURNAL OF CLINICAL MEDICINE211
- SEMINARS IN THROMBOSIS AND HEMOST...196
- HAEMATOLOGICA188
Serie
- BEITRÄGE ZUR FREMDSPRACHENVERMITT...1
Keyword
- Humans3147
- Female1675
- Male1627
- Middle Aged1157
- Aged999
- Adult973
- COVID-19944
- Italy720
- children537
- Treatment Outcome468
Lingua
- eng53656
- ita15740
- fre577
- spa481
- ger303
- por53
- und46
- rus45
- lat31
- enm25
Accesso al fulltext
- no fulltext53288
- open10384
- restricted4209
- reserved2856
- partially open42
- embargoed17
- mixed12